GIUSEPPE DI BELLA > NEWS > null > null > La Melatonina nelle malattie linfoproliferative

 
La Melatonina nelle malattie linfoproliferative di S.I.B.O.R. - M.D.B.
 
 
Data: 14/07/2006
Tipologia: MDB - Documentazione
Lingua: Italiano
Anno: 2006
 
 
Descrizione:
PER LEGGERE E SCARICARE IL CAPITOLO SULLA MELATONINA, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 59 pagine in formato PDF e pesa 235 kb.



BIBLIOGRAFIA





Anwar, M. M., H. A. Mahfouz, et al. (1998). "Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs." Comp Biochem Physiol A Mol Integr Physiol 119(2): 493-501.





Barjavel, M. J., Z. Mamdouh, et al. (1998). "Differential expression of the melatonin receptor in human monocytes." J Immunol 160(3): 1191-7.





Benitez-King, G. and F. Anton-Tay (1993). "Calmodulin mediates melatonin cytoskeletal effects." Experientia 49(8): 635-41.





Blask, D. E., L. A. Sauer, et al. (2002). "Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy." Curr Top Med Chem 2(2): 113-32.





Cagnacci, A. (1996). "Melatonin in relation to physiology in adult humans." J Pineal Res 21(4): 200-13.





Carrillo-Vico, A., J. R. Calvo, et al. (2004). "Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance." Faseb J 18(3): 537-9.





Colombo, L. L., G. J. Chen, et al. (1992). "Melatonin induced increase in gamma-interferon production by murine splenocytes." Immunol Lett 33(2): 123-6.





Conti, A., S. Conconi, et al. (2000). "Evidence for melatonin synthesis in mouse and human bone marrow cells." J Pineal Res 28(4): 193-202.





Csaba, G. and P. Barath (1975). "Morphological changes of thymus and the thyroid gland after postnatal extirpation of pineal body." Endocrinol Exp 9(1): 59-67.





del Gobbo, V., V. Libri, et al. (1989). "Pinealectomy inhibits interleukin-2 production and natural killer activity in mice." Int J Immunopharmacol 11(5): 567-73.





Di Bella, L., C. Bruschi, et al. (2002). "Melatonin effects on megakaryocyte membrane patch-clamp outward K+ current." Med Sci Monit 8(12): BR527-31.





Garcia-Maurino, S., M. G. Gonzalez-Haba, et al. (1998). "Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells." J Neuroimmunol 92(1-2): 76-84.





Garcia-Maurino, S., M. G. Gonzalez-Haba, et al. (1997). "Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes." J Immunol 159(2): 574-81.





Garcia-Maurino, S., D. Pozo, et al. (1999). "Melatonin activates Th1 lymphocytes by increasing IL-12 production." Life Sci 65(20): 2143-50.





Garcia-Perganeda, A., D. Pozo, et al. (1997). "Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein." J Immunol 159(8): 3774-81.





Giordano, M. and M. S. Palermo (1991). "Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity." J Pineal Res 10(3): 117-21.





Gonzalez-Haba, M. G., S. Garcia-Maurino, et al. (1995). "High-affinity binding of melatonin by human circulating T lymphocytes (CD4+)." Faseb J 9(13): 1331-5.





Guerrero, J. M. and R. J. Reiter (1992). "A brief survey of pineal gland-immune system interrelationships." Endocr Res 18(2): 91-113.





Hill, S. M., L. L. Spriggs, et al. (1992). "The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system." Cancer Lett 64(3): 249-56.





Jankovic, B. D., K. Isakovic, et al. (1970). "Effect of pinealectomy on immune reactions in the rat." Immunology 18(1): 1-6.





Karbownik, M. (2002). "Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms." Neuro Endocrinol Lett 23 Suppl 1: 39-44.





Konakchieva, R., S. Kyurkchiev, et al. (1995). "Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells." J Neuroimmunol 63(2): 125-32.





Lissoni, P., S. Barni, et al. (1993). "Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results." Eur J Cancer 29A(2): 185-9.





Lissoni, P., A. Bastone, et al. (1987). "The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels." Eur J Cancer Clin Oncol 23(7): 949-57.





Lissoni, P., S. Bolis, et al. (2000). "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies." Anticancer Res 20(3B): 2103-5.





Lissoni, P., F. Rovelli, et al. (2001). "Anti-angiogenic activity of melatonin in advanced cancer patients." Neuro Endocrinol Lett 22(1): 45-7.





Lissoni, P., G. Tancini, et al. (1996). "The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia." Recenti Prog Med 87(12): 582-5.





Lopez-Gonzalez, M. A., J. R. Calvo, et al. (1992). "Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP." J Pineal Res 12(3): 97-104.





Macchi, M. M. and J. N. Bruce (2004). "Human pineal physiology and functional significance of melatonin." Front Neuroendocrinol 25(3-4): 177-95.





Manchester, L. C., B. Poeggeler, et al. (1995). "Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system." Cell Mol Biol Res 41(5): 391-5.





Markowska, M., M. Waloch, et al. (2001). "Melatonin inhibits PHA-stimulated chicken lymphocyte proliferation in vitro." J Pineal Res 30(4): 220-6.





Morrey, K. M., J. A. McLachlan, et al. (1994). "Activation of human monocytes by the pineal hormone melatonin." J Immunol 153(6): 2671-80.





Neri, B., C. Fiorelli, et al. (1994). "Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study." Cancer 73(12): 3015-9.





Panzer, A. and M. Viljoen (1997). "The validity of melatonin as an oncostatic agent." J Pineal Res 22(4): 184-202.





Pawlikowski, M., K. Winczyk, et al. (2002). "Oncostatic action of melatonin: facts and question marks." Neuro Endocrinol Lett 23 Suppl 1: 24-9.





Poon, A. M., A. S. Mak, et al. (1996). "Melatonin and 2[125I]iodomelatonin binding sites in the human colon." Endocr Res 22(1): 77-94.





Rapozzi, V., S. Zorzet, et al. (1998). "Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma." Life Sci 63(19): 1701-13.





Reiter, R. J. (1991). "Pineal melatonin: cell biology of its synthesis and of its physiological interactions." Endocr Rev 12(2): 151-80.





Reiter, R. J., D. X. Tan, et al. (2002). "Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging." Ann N Y Acad Sci 959: 238-50.





Reppert, S. M., C. Godson, et al. (1995). "Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor." Proc Natl Acad Sci U S A 92(19): 8734-8.





Skwarlo-Sonta, K. (2002). "Melatonin in immunity: comparative aspects." Neuro Endocrinol Lett 23 Suppl 1: 61-6.





Slaugenhaupt, S. A., A. L. Roca, et al. (1995). "Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a)." Genomics 27(2): 355-7.





Soto-Vega, E., I. Meza, et al. (2004). "Melatonin stimulates calmodulin phosphorylation by protein kinase C." J Pineal Res 37(2): 98-106.





Sugden, D. (1989). "Melatonin biosynthesis in the mammalian pineal gland." Experientia 45(10): 922-32.





Sugden, D., K. Davidson, et al. (2004). "Melatonin, melatonin receptors and melanophores: a moving story." Pigment Cell Res 17(5): 454-60.





Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.





Vacas, M. I., M. M. Del Zar, et al. (1992). "Binding sites for [3H]-melatonin in human platelets." J Pineal Res 13(2): 60-5.





van Vuuren, R. J., M. J. Pitout, et al. (1992). "Putative melatonin receptor in human spermatozoa." Clin Biochem 25(2): 125-7.





Vijayalaxmi, R. J. Reiter, et al. (2004). "Melatonin as a radioprotective agent: a review." Int J Radiat Oncol Biol Phys 59(3): 639-53.





Yie, S. M., L. P. Niles, et al. (1995). "Melatonin receptors on human granulosa cell membranes." J Clin Endocrinol Metab 80(5): 1747-9.

 
 
 

PER LEGGERE E SCARICARE IL CAPITOLO SULLA MELATONINA, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 59 pagine in formato PDF e pesa 235 kb.



BIBLIOGRAFIA





Anwar, M. M., H. A. Mahfouz, et al. (1998). "Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs." Comp Biochem Physiol A Mol Integr Physiol 119(2): 493-501.





Barjavel, M. J., Z. Mamdouh, et al. (1998). "Differential expression of the melatonin receptor in human monocytes." J Immunol 160(3): 1191-7.





Benitez-King, G. and F. Anton-Tay (1993). "Calmodulin mediates melatonin cytoskeletal effects." Experientia 49(8): 635-41.





Blask, D. E., L. A. Sauer, et al. (2002). "Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy." Curr Top Med Chem 2(2): 113-32.





Cagnacci, A. (1996). "Melatonin in relation to physiology in adult humans." J Pineal Res 21(4): 200-13.





Carrillo-Vico, A., J. R. Calvo, et al. (2004). "Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance." Faseb J 18(3): 537-9.





Colombo, L. L., G. J. Chen, et al. (1992). "Melatonin induced increase in gamma-interferon production by murine splenocytes." Immunol Lett 33(2): 123-6.





Conti, A., S. Conconi, et al. (2000). "Evidence for melatonin synthesis in mouse and human bone marrow cells." J Pineal Res 28(4): 193-202.





Csaba, G. and P. Barath (1975). "Morphological changes of thymus and the thyroid gland after postnatal extirpation of pineal body." Endocrinol Exp 9(1): 59-67.





del Gobbo, V., V. Libri, et al. (1989). "Pinealectomy inhibits interleukin-2 production and natural killer activity in mice." Int J Immunopharmacol 11(5): 567-73.





Di Bella, L., C. Bruschi, et al. (2002). "Melatonin effects on megakaryocyte membrane patch-clamp outward K+ current." Med Sci Monit 8(12): BR527-31.





Garcia-Maurino, S., M. G. Gonzalez-Haba, et al. (1998). "Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells." J Neuroimmunol 92(1-2): 76-84.





Garcia-Maurino, S., M. G. Gonzalez-Haba, et al. (1997). "Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes." J Immunol 159(2): 574-81.





Garcia-Maurino, S., D. Pozo, et al. (1999). "Melatonin activates Th1 lymphocytes by increasing IL-12 production." Life Sci 65(20): 2143-50.





Garcia-Perganeda, A., D. Pozo, et al. (1997). "Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein." J Immunol 159(8): 3774-81.





Giordano, M. and M. S. Palermo (1991). "Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity." J Pineal Res 10(3): 117-21.





Gonzalez-Haba, M. G., S. Garcia-Maurino, et al. (1995). "High-affinity binding of melatonin by human circulating T lymphocytes (CD4+)." Faseb J 9(13): 1331-5.





Guerrero, J. M. and R. J. Reiter (1992). "A brief survey of pineal gland-immune system interrelationships." Endocr Res 18(2): 91-113.





Hill, S. M., L. L. Spriggs, et al. (1992). "The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system." Cancer Lett 64(3): 249-56.





Jankovic, B. D., K. Isakovic, et al. (1970). "Effect of pinealectomy on immune reactions in the rat." Immunology 18(1): 1-6.





Karbownik, M. (2002). "Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms." Neuro Endocrinol Lett 23 Suppl 1: 39-44.





Konakchieva, R., S. Kyurkchiev, et al. (1995). "Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells." J Neuroimmunol 63(2): 125-32.





Lissoni, P., S. Barni, et al. (1993). "Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results." Eur J Cancer 29A(2): 185-9.





Lissoni, P., A. Bastone, et al. (1987). "The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels." Eur J Cancer Clin Oncol 23(7): 949-57.





Lissoni, P., S. Bolis, et al. (2000). "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies." Anticancer Res 20(3B): 2103-5.





Lissoni, P., F. Rovelli, et al. (2001). "Anti-angiogenic activity of melatonin in advanced cancer patients." Neuro Endocrinol Lett 22(1): 45-7.





Lissoni, P., G. Tancini, et al. (1996). "The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia." Recenti Prog Med 87(12): 582-5.





Lopez-Gonzalez, M. A., J. R. Calvo, et al. (1992). "Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP." J Pineal Res 12(3): 97-104.





Macchi, M. M. and J. N. Bruce (2004). "Human pineal physiology and functional significance of melatonin." Front Neuroendocrinol 25(3-4): 177-95.





Manchester, L. C., B. Poeggeler, et al. (1995). "Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system." Cell Mol Biol Res 41(5): 391-5.





Markowska, M., M. Waloch, et al. (2001). "Melatonin inhibits PHA-stimulated chicken lymphocyte proliferation in vitro." J Pineal Res 30(4): 220-6.





Morrey, K. M., J. A. McLachlan, et al. (1994). "Activation of human monocytes by the pineal hormone melatonin." J Immunol 153(6): 2671-80.





Neri, B., C. Fiorelli, et al. (1994). "Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study." Cancer 73(12): 3015-9.





Panzer, A. and M. Viljoen (1997). "The validity of melatonin as an oncostatic agent." J Pineal Res 22(4): 184-202.





Pawlikowski, M., K. Winczyk, et al. (2002). "Oncostatic action of melatonin: facts and question marks." Neuro Endocrinol Lett 23 Suppl 1: 24-9.





Poon, A. M., A. S. Mak, et al. (1996). "Melatonin and 2[125I]iodomelatonin binding sites in the human colon." Endocr Res 22(1): 77-94.





Rapozzi, V., S. Zorzet, et al. (1998). "Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma." Life Sci 63(19): 1701-13.





Reiter, R. J. (1991). "Pineal melatonin: cell biology of its synthesis and of its physiological interactions." Endocr Rev 12(2): 151-80.





Reiter, R. J., D. X. Tan, et al. (2002). "Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging." Ann N Y Acad Sci 959: 238-50.





Reppert, S. M., C. Godson, et al. (1995). "Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor." Proc Natl Acad Sci U S A 92(19): 8734-8.





Skwarlo-Sonta, K. (2002). "Melatonin in immunity: comparative aspects." Neuro Endocrinol Lett 23 Suppl 1: 61-6.





Slaugenhaupt, S. A., A. L. Roca, et al. (1995). "Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a)." Genomics 27(2): 355-7.





Soto-Vega, E., I. Meza, et al. (2004). "Melatonin stimulates calmodulin phosphorylation by protein kinase C." J Pineal Res 37(2): 98-106.





Sugden, D. (1989). "Melatonin biosynthesis in the mammalian pineal gland." Experientia 45(10): 922-32.





Sugden, D., K. Davidson, et al. (2004). "Melatonin, melatonin receptors and melanophores: a moving story." Pigment Cell Res 17(5): 454-60.





Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.





Vacas, M. I., M. M. Del Zar, et al. (1992). "Binding sites for [3H]-melatonin in human platelets." J Pineal Res 13(2): 60-5.





van Vuuren, R. J., M. J. Pitout, et al. (1992). "Putative melatonin receptor in human spermatozoa." Clin Biochem 25(2): 125-7.





Vijayalaxmi, R. J. Reiter, et al. (2004). "Melatonin as a radioprotective agent: a review." Int J Radiat Oncol Biol Phys 59(3): 639-53.





Yie, S. M., L. P. Niles, et al. (1995). "Melatonin receptors on human granulosa cell membranes." J Clin Endocrinol Metab 80(5): 1747-9.

 
 
 

 

Documento Allegato

Stampa